Vericel Corp at Morgan Stanley Healthcare Conference Transcript
Good afternoon, everyone. My name is Jonathan Guskind from Morgan Stanley's Healthcare Investment Banking team. It's my pleasure today to have with us from Vericel, Nick Colangelo, the Chief Executive Officer.
Before we get started, just a quick note. Please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures, appear on the Morgan Stanley public website at www.morganstanley.com/researchdisclosures or at the registration desk.
Nick, thanks again for joining us at the conference. To get started, why don't we start with a brief overview of Vericel and its evolution over the past few years?
Yes. Well, great, John. Thanks for having us here. We're really excited. And before I begin, I'll just say that our discussion will contain some forward
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |